An international team that includes multiple Rutgers scientists has made significant progress in understanding the genetic causes of Tourette syndrome. They estimate that over 400 singular or combined mutated genes could pose a risk for Tourette syndrome, suggesting the disorder is as complex as autism, epilepsy, and intellectual disability
All news from Anaesthesiology
Mothers and babies are dying due to birth-associated complications at higher rates now than a decade ago. In a new study appearing online in Birth, Katherine Campbell, assistant professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine, and her team found that that jointly considering morbidity outcomes for mom and baby is the best way to measure the quality of a hospital's obstetrics program
A new oral drug for use in patients with certain blood cancers has been approved by the US Food and Drug Administration (FDA). The drug, duvelisib (Copiktra, Verstem Oncology), is an oral inhibitor of phosphoinositide 3–kinase (PI3K) and is the first to act as a dual inhibitor of PI3K-delta and PI3K-gamma.
About half of women who routinely get mammograms have not heard of the term "baseline mammogram," a recent study suggests. Baseline mammograms have been shown to reduce the odds of false-positive results in future mammograms, the study authors noted September 12 online in the Journal of the American College of Radiology.
NUS biologists have developed cyclic peptides that can trigger cancer cell death without affecting healthy cells. The glucose-regulated protein 78?kDa (known as GRP78) is emerging as a target for cancer therapy and a biomarker for cancer prognosis.
Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Todayowever, novel immunotherapeutics across different tumor types, either as monotherapy or in combination, are increasingly becoming one of the most innovative and powerful anti-cancer strategies.
In a rare bipartisan move, both the House and Senate have reached a compromise on legislation to address the opioid epidemic. Another part of the legislation could make it easier for Medicaid recipients to get inpatient care for substance abuse over the next five years.